Outcome of 30th Annual General Meeting held on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited held its 30th AGM on 30th September 2025 via video conferencing from 11:30 AM to 11:53 AM. Eleven resolutions were put to vote, covering adoption of FY25 audited financial statements, re-appointment of Managing Director Ghanshyam Gavali by rotation, and appointment of M/s Sunit M Chhatbar & Co as statutory auditor for five years (until 2030). Special resolutions included a change in statutory auditor to fill a casual vacancy, change in designation of the MD, regularisation of a Non-Executive Director, a proposed change in the company's name, alteration of the object clause, adoption of new MOA and AOA, and an increase in the company's borrowing limits. Quorum was present and voting was conducted via remote e-voting and e-voting at the meeting, with results to be announced within two working days.
Several special resolutions signal material corporate changes — including a possible name change, expansion of business objects, higher borrowing capacity, and a switch of statutory auditor. Shareholders should watch for the e-voting results within two working days, as these items could affect the company's future direction and risk profile.